| Dr Marco John Tatangelo, MD | |
|
2700 Baker St Fl 3, Muskegon, MI 49444-2157 | |
| (231) 737-1335 | |
| Not Available |
| Full Name | Dr Marco John Tatangelo |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2700 Baker St Fl 3, Muskegon, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477992147 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301103115 (Michigan) | Primary |
| Entity Name | Hackley Community Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629066238 PECOS PAC ID: 8123015492 Enrollment ID: O20040511001126 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
UCD Conway researchers have found that carbon dioxide (CO2) is not only involved in climate change and a waste product of respiration in cells but also plays an active role in regulating the genes involved in inflammation and innate immunity. Their research findings were highlighted recently in the The Journal of Immunology.
The controversy about whether eggs are good or bad for your heart health may be solved, and about one a day is fine.
Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine works, which they hope will lead to the development of new, safer and more effective treatments for malaria.
Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical technology company developing brain stimulation products, today announced that it has raised €7.5 m from the Dutch investment group INKEF Capital, in a further extension of their Series A financing round. The proceeds will be used for the development of its Steering Brain Stimulation implant and procedure solutions to treat Parkinson's disease (PD) and other functional brain disorders.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marco John Tatangelo, MD 2700 Baker St Fl 3, Muskegon, MI 49444-2157 Ph: (231) 737-1335 | Dr Marco John Tatangelo, MD 2700 Baker St Fl 3, Muskegon, MI 49444-2157 Ph: (231) 737-1335 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
UCD Conway researchers have found that carbon dioxide (CO2) is not only involved in climate change and a waste product of respiration in cells but also plays an active role in regulating the genes involved in inflammation and innate immunity. Their research findings were highlighted recently in the The Journal of Immunology.
The controversy about whether eggs are good or bad for your heart health may be solved, and about one a day is fine.
Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine works, which they hope will lead to the development of new, safer and more effective treatments for malaria.
Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical technology company developing brain stimulation products, today announced that it has raised €7.5 m from the Dutch investment group INKEF Capital, in a further extension of their Series A financing round. The proceeds will be used for the development of its Steering Brain Stimulation implant and procedure solutions to treat Parkinson's disease (PD) and other functional brain disorders.
› Verified 7 days ago
Elizabeth Fisher Pallante, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3535 Park St, Suite 101, Muskegon, MI 49444 Phone: 231-737-0411 Fax: 231-739-8502 | |
Richard John Golz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3535 Park St, Suite 101, Muskegon, MI 49444 Phone: 231-739-2121 Fax: 231-739-4130 | |
Dr. Howard Vernon Sanden, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 972 Randall Rd, Muskegon, MI 49441 Phone: 231-798-7653 Fax: 231-798-7653 | |
Danny D. Mikesell, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 684 Harvey St, Ste 201, Muskegon, MI 49442 Phone: 231-773-7837 Fax: 231-773-7943 | |
Michael James Galvin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3535 Park St, Suite 101, Muskegon, MI 49444 Phone: 231-739-2121 Fax: 231-739-4130 | |
Regina Ramirez, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 684 Harvey St Ste 201, Muskegon, MI 49442 Phone: 231-777-2732 Fax: 231-773-8979 | |
Dr. Robington J.o. Woods, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 684 Harvey St, Suite 201, Muskegon, MI 49442 Phone: 231-773-7837 Fax: 231-773-7943 |